Security key
28617K101
Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)
CUSIP: 28617K101
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 78,762,953
- Total 13F shares
- 36,469,559
- Share change
- -4,359,282
- Total reported value
- $94,453,818
- Price per share
- $2.59
- Number of holders
- 82
- Value change
- -$12,219,070
- Number of buys
- 41
- Number of sells
- 44
Report period
Q3 2025
Institutions
82
Top holders
10
ELDN full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Eledon Pharmaceuticals, Inc. SEC filings
Eledon Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 28617K101
Recent filing periods:
Top shareholders of ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
— |
5%
|
3,137,553
|
$10,259,798 | $0 | 31 Dec 2024 | |
| Frazier Life Sciences Public Fund, L.P. |
13D/G
|
James N. Topper |
2%
|
1,176,735
|
$3,847,923 | $0 | 31 Dec 2024 | |
| BVF INC/IL |
13F
|
Company |
8%
|
6,293,282
|
$17,054,794 | — | 30 Jun 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
4.5%
|
3,566,338
|
$9,664,776 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.2%
|
3,318,383
|
$8,992,818 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.1%
|
3,254,152
|
$8,818,751 | — | 30 Jun 2025 | |
| First Light Asset Management, LLC |
13F
|
Company |
3.3%
|
2,600,498
|
$7,047,350 | — | 30 Jun 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
2.5%
|
1,959,610
|
$5,310,543 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
2.1%
|
1,671,822
|
$4,530,638 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
1,383,940
|
$3,751,041 | — | 30 Jun 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
1.7%
|
1,329,912
|
$3,604,062 | — | 30 Jun 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.6%
|
1,264,919
|
$3,427,930 | — | 30 Jun 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.4%
|
1,141,237
|
$3,092,752 | — | 30 Jun 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
1.4%
|
1,100,473
|
$2,982,282 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.3%
|
1,018,919
|
$2,761,270 | — | 30 Jun 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.3%
|
1,000,221
|
$2,710,599 | — | 30 Jun 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
1.3%
|
998,454
|
$2,705,810 | — | 30 Jun 2025 | |
| Zimmer Partners, LP |
13F
|
Company |
1.2%
|
980,682
|
$2,657,648 | — | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
1.2%
|
933,475
|
$2,529,717 | — | 30 Jun 2025 | |
| Sanofi |
13F
|
Company |
1%
|
814,980
|
$2,208,596 | — | 30 Jun 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.88%
|
690,170
|
$1,870,361 | — | 30 Jun 2025 | |
| 22NW, LP |
13F
|
Company |
0.81%
|
636,364
|
$1,724,546 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.77%
|
605,340
|
$1,640,471 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.58%
|
454,077
|
$1,230,548 | — | 30 Jun 2025 | |
| CM Management, LLC |
13F
|
Company |
0.48%
|
375,000
|
$1,016,250 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.44%
|
345,629
|
$936,655 | — | 30 Jun 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.43%
|
338,973
|
$918,617 | — | 30 Jun 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
293,565
|
$795,561 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.24%
|
190,673
|
$516,724 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
177,249
|
$480,345 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.22%
|
171,669
|
$465,223 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.19%
|
152,460
|
$413,167 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.17%
|
136,456
|
$369,673 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
134,322
|
$364,012 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
126,266
|
$342,181 | — | 30 Jun 2025 | |
| Exome Asset Management LLC |
13F
|
Company |
0.14%
|
114,145
|
$309,333 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
101,878
|
$276,090 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.12%
|
94,772
|
$256,832 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.1%
|
76,292
|
$206,751 | — | 30 Jun 2025 | |
| DIADEMA PARTNERS LP |
13F
|
Company |
0.08%
|
64,613
|
$175,101 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
56,050
|
$151,888 | — | 30 Jun 2025 | |
| INGALLS & SNYDER LLC |
13F
|
Company |
0.07%
|
51,849
|
$141,000 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.05%
|
40,155
|
$109,000 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
37,156
|
$100,693 | — | 30 Jun 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.05%
|
36,400
|
$98,644 | — | 30 Jun 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.05%
|
36,264
|
$98,276 | — | 30 Jun 2025 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
36,141
|
$97,942 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.05%
|
35,592
|
$96,454 | — | 30 Jun 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
33,400
|
$90,514 | — | 30 Jun 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.04%
|
32,052
|
$86,861 | — | 30 Jun 2025 |
Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) as of Q3 2025
As of 30 Sep 2025,
Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,469,559 shares.
The largest 10 holders included
BVF INC/IL, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., VANGUARD GROUP INC, Siren, L.L.C., Zimmer Partners, LP, GEODE CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, SPHERA FUNDS MANAGEMENT LTD., and Ensign Peak Advisors, Inc.
This page lists
82
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
85
Q3 2025 holders
82
Holder diff
-3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.